Optimizerx CORP (OPRX) — 10-Q Filings

All 10-Q filings from Optimizerx CORP. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

OptimizeRx Swings to Profit on Strong Revenue Growth, Operational Gains — Nov 7, 2025 Risk: medium
OptimizeRx Corp (OPRX) reported a significant turnaround in its financial performance for the three and nine months ended September 30, 2025. Net revenue for th
OptimizeRx Q2 Revenue Jumps 28% on Strong Digital Health Demand — Aug 8, 2025 Risk: medium
OptimizeRx Corp reported a significant increase in revenue for the three and six months ended June 30, 2025. Revenue for the second quarter of 2025 reached $35.
OptimizeRx Corp Q1 2025 10-Q Filed — May 13, 2025 Risk: low
OptimizeRx Corp filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes i
OptimizeRx Corp Files Q3 2024 10-Q — Nov 14, 2024 Risk: low
OptimizeRx Corp filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Nevada, is headquartered in Waltham, MA. The fili
OptimizeRx Corp Files Q2 2024 10-Q Report — Aug 15, 2024 Risk: low
OptimizeRx Corp filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Nevada, is headquartered in Waltham, MA. This filing p
OptimizeRx Corp Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
OptimizeRx Corp (OPRX) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. OptimizeRx Corp filed a 10-Q report for the quarterly period ended March 31

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX